Kamato T[au] - Search Results

Year	Number of Results
1985	1
1990	2
1991	4
1992	3
1993	4
1994	3
1995	8
1996	2
1997	3
1999	1
2000	1
2001	1
2002	1
2023	0

1

Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets.

Kamato T, Ito H, Nagakura Y, Nishida A, Yuki H, Yamano M, Miyata K. Kamato T, et al. Eur J Pharmacol. 1993 Jul 20;238(2-3):369-76. doi: 10.1016/0014-2999(93)90868-i. Eur J Pharmacol. 1993. PMID: 8405104

2

Role of the serotonin3 receptor in stress-induced defecation.

Miyata K, Kamato T, Nishida A, Ito H, Yuki H, Yamano M, Tsutsumi R, Katsuyama Y, Honda K. Miyata K, et al. Among authors: kamato t. J Pharmacol Exp Ther. 1992 Apr;261(1):297-303. J Pharmacol Exp Ther. 1992. PMID: 1560375

3

A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.

Kiso T, Ito H, Miyata K, Kamato T, Naitoh Y, Iwaoka K, Yamaguchi T. Kiso T, et al. Among authors: kamato t. Eur J Pharmacol. 2001 Nov 9;431(1):35-41. doi: 10.1016/s0014-2999(01)01425-x. Eur J Pharmacol. 2001. PMID: 11716840

4

Studies on the mechanism for the gastric mucosal protection by famotidine in rats.

Miyata K, Kamato T, Nishida A, Honda K. Miyata K, et al. Among authors: kamato t. Jpn J Pharmacol. 1991 Feb;55(2):211-22. doi: 10.1254/jjp.55.211. Jpn J Pharmacol. 1991. PMID: 2067140 Free article.

5

Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.

Yamano M, Kamato T, Nagakura Y, Miyata K. Yamano M, et al. Among authors: kamato t. Naunyn Schmiedebergs Arch Pharmacol. 1997 Jul;356(1):145-50. doi: 10.1007/pl00005022. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9228202

6

Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.

Ito H, Kiso T, Miyata K, Kamato T, Yuki H, Akuzawa S, Nagakura Y, Yamano M, Suzuki M, Naitoh Y, Sakai H, Iwaoka K, Yamaguchi T. Ito H, et al. Among authors: kamato t. Eur J Pharmacol. 2000 Dec 8;409(2):195-201. doi: 10.1016/s0014-2999(00)00851-7. Eur J Pharmacol. 2000. PMID: 11104834

7

Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.

Nagakura Y, Naitoh Y, Kamato T, Yamano M, Miyata K. Nagakura Y, et al. Among authors: kamato t. Eur J Pharmacol. 1996 Sep 5;311(1):67-72. doi: 10.1016/0014-2999(96)00403-7. Eur J Pharmacol. 1996. PMID: 8884238

8

Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.

Yamano M, Kamato T, Nishida A, Ito H, Yuki H, Tsutsumi R, Honda K, Miyata K. Yamano M, et al. Among authors: kamato t. Jpn J Pharmacol. 1994 Jul;65(3):241-8. doi: 10.1254/jjp.65.241. Jpn J Pharmacol. 1994. PMID: 7799524 Free article.

9

Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.

Kamato T, Miyata K, Ito H, Yuki H, Yamano M, Honda K. Kamato T, et al. Jpn J Pharmacol. 1991 Nov;57(3):387-95. doi: 10.1254/jjp.57.387. Jpn J Pharmacol. 1991. PMID: 1813664 Free article.

10

Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.

Yuki H, Kamato T, Nishida A, Fujihara A, Takeda M, Miyata K. Yuki H, et al. Among authors: kamato t. Jpn J Pharmacol. 1993 Nov;63(3):345-51. doi: 10.1254/jjp.63.345. Jpn J Pharmacol. 1993. PMID: 7906319 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results